The U.S. Food and Drug Administration announced that it has approved an amended application submitted by Teva Women’s Health, Inc. to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years of age and older. After the FDA did not approve Teva’s application to make Plan B One-Step available over-the-counter for all females of reproductive age in December 2011, the company submitted an amended application to make the product available for women 15 years of age and older without a prescription.
Plan B One-Step is an emergency contraceptive intended to reduce the possibility of pregnancy following unprotected sexual intercourse – if another form of birth control (e.g., condom) was not used or failed. Plan B One-Step is a single-dose pill (1.5 mg tablet) that is most effective in decreasing the possibility of unwanted pregnancy if taken immediately or within 3 days after unprotected sexual intercourse.
FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older
You may also be interested in
Family Planning Communications
This report looks at the evidence available on effective behaviour change communication for increasing the uptake of family planning methods. It provides information on several different methods. Studies indicate that if a woman has been given advice to adopt postpartum contraception three or more times, the couple are more likely to have adopted a method…. Read more
Benefits of Investing in Family Planning
This report focuses on the evidence on the health, economic and other benefits of investing in family planning. Family planning allows people to attain their desired number of children and determine the spacing of pregnancies. It is achieved through use of contraceptive methods and the treatment of infertility (WHO 2015). A large and growing body… Read more